Showing results (1-10 of 36) with videos related to
Sort By:
Pageof 4
Immunity|March 10, 2021
Immunotherapeutic strategies to target vulnerabilities in the Ebolavirus glycoproteinJohn Misasi, Nancy J SullivanCell|November 24, 2014
Camouflage and misdirection: the full-on assault of ebola virus diseaseJohn Misasi, Nancy J SullivanProtein Expression and Purification|May 2, 2017
Overexpression of Ebola virus envelope GP1 proteinZhongcheng Zou, John Misasi, Nancy Sullivan, et al.Trends in Pharmacological Sciences|October 16, 2023
Exploring host-virus interaction to improve immunotherapy against Ebola virusDacquin M Kasumba, John Misasi, Sabue Mulangu, et al.ACS Medicinal Chemistry Letters|March 26, 2013
Inhibition of Ebola Virus Infection: Identification of Niemann-Pick C1 as the Target by Optimization of a Chemical ProbeKyungae Lee, Tao Ren, Marceline Côté, et al.The Journal of Infectious Diseases|August 24, 2018
Vaccine-Mediated Induction of an Ebolavirus Cross-Species Antibody Binding to Conserved Epitopes on the Glycoprotein Heptad Repeat 2/Membrane-Proximal External JunctionAlberto Cagigi, Aurélie Ploquin, Thomas Niezold, et al.Emerging Infectious Diseases|January 25, 2013
Eastern equine encephalitis in children, Massachusetts and New Hampshire,USA, 1970-2010Michael A Silverman, John Misasi, Sandra Smole, et al.The Journal of Infectious Diseases|July 17, 2018
Vaccine Generation of Protective Ebola Antibodies and Identification of Conserved B-Cell SignaturesAlberto Cagigi, John Misasi, Aurélie Ploquin, et al.Journal of Virology|January 13, 2012
Filoviruses require endosomal cysteine proteases for entry but exhibit distinct protease preferencesJohn Misasi, Kartik Chandran, Jin-Yi Yang, et al.Nature|August 26, 2011
Small molecule inhibitors reveal Niemann-Pick C1 is essential for Ebola virus infectionMarceline Côté, John Misasi, Tao Ren, et al.Pageof 4